The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AEGERION PHARMACEUTICALSAEGR 5 04/01/25 | NOTE 5.000% 4/0 | 00767EAC6 | 2,886 | 3,037,627 | PRN | SOLE | 3,037,627 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 3,361 | 1,162,876 | SH | SOLE | 1,162,876 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 4,740 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| APPLIED GENETIC TECHNOLOGIES | COM | 03820J100 | 1,925 | 586,969 | SH | SOLE | 586,969 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 5,252 | 1,313,100 | SH | SOLE | 1,313,100 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 3,233 | 1,683,861 | SH | SOLE | 1,683,861 | 0 | 0 | ||
| ANTARES PHARMA INC | COM | 036642106 | 357 | 151,189 | SH | SOLE | 151,189 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 2,861 | 755,000 | SH | SOLE | 755,000 | 0 | 0 | ||
| BAUDAX BIO INC | COM | 07160F107 | 1,513 | 610,200 | SH | SOLE | 610,200 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 4,454 | 1,019,196 | SH | SOLE | 1,019,196 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 3,231 | 1,302,981 | SH | SOLE | 1,302,981 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 2,716 | 744,134 | SH | SOLE | 744,134 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 3,295 | 907,735 | SH | SOLE | 907,735 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 5,916 | 6,430,637 | SH | SOLE | 6,430,637 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 2,311 | 825,297 | SH | SOLE | 825,297 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 3,415 | 822,960 | SH | SOLE | 822,960 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 323 | 992,641 | SH | SOLE | 992,641 | 0 | 0 | ||
| INTERPACE BIOSCIENCES INC | COM | 46062X303 | 924 | 178,295 | SH | SOLE | 178,295 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 8,888 | 2,583,786 | SH | SOLE | 2,583,786 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 11,702 | 160,919 | SH | SOLE | 160,919 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 3,518 | 4,690,146 | SH | SOLE | 4,690,146 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 3,649 | 380,948 | SH | SOLE | 380,948 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 3,467 | 374,431 | SH | SOLE | 374,431 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 16 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| SEASPINE HOLDINGS CORP | COM | 81255T108 | 2,068 | 253,131 | SH | SOLE | 253,131 | 0 | 0 | ||
| STEMLINE THERAPEUTICS INC | COM | 85858C107 | 4,291 | 886,632 | SH | SOLE | 886,632 | 0 | 0 | ||
| XOMA CORP | COM | 98419J206 | 4,245 | 208,600 | SH | SOLE | 208,600 | 0 | 0 | ||